Literature DB >> 15233318

Generalized additive model demonstrates fluoroquinolone use/resistance relationships for Staphylococcus aureus.

Pierre Berger1, Laurence Pascal, Catherine Sartor, Jean Delorme, Philippe Monge, Christine Penot Ragon, Martine Charbit, Roland Sambuc, Michel Drancourt.   

Abstract

Mathematical models currently used to study the relationship between the prevalence of the resistance to an antibiotic and the amount of drug may not be adequate because they do not integrate temporal and area analyses simultaneously. Furthermore, the forms of such relationship are unknown. We applied the Generalized Additive Model (GAM) to study fluoroquinolone use and the incidence of fluoroquinolone-resistance in Staphylococcus aureus in our institution over a 3-year period. Overall institution and individual hospital unitrestricted analyses were performed. Relative risk (RR) observed for increasing fluoroquinolone use with a 4-month lag from the 25th percentile to the 75th percentile was 1.27 (95% CI: 1.13-1.42). In the surgery units, RR was 1.23 (95% CI: 1.01-1.50) for fluoroquinolone use with a 2-months lag. GAM enabled us to observe for the first time a significant temporal relationship between fluoroquinolone use and the incidence of fluoroquinolone-resistant nosocomial S. aureus isolates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233318     DOI: 10.1023/b:ejep.0000027348.92979.94

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  38 in total

Review 1.  Surveillance of antibiotic resistance in European ICUs.

Authors:  H Hanberger; D Diekema; A Fluit; R Jones; M Struelens; R Spencer; M Wolff
Journal:  J Hosp Infect       Date:  2001-07       Impact factor: 3.926

2.  Comparing meta-analysis and ecological-longitudinal analysis in time-series studies. A case study of the effects of air pollution on mortality in three Spanish cities.

Authors:  M Saez; A Figueiras; F Ballester; S Pérez-Hoyos; R Ocaña; A Tobías
Journal:  J Epidemiol Community Health       Date:  2001-06       Impact factor: 3.710

3.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Diekema; M A Pfaller; F J Schmitz; J Smayevsky; J Bell; R N Jones; M Beach
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals.

Authors:  N S Crowcroft; O Ronveaux; D L Monnet; R Mertens
Journal:  Infect Control Hosp Epidemiol       Date:  1999-01       Impact factor: 3.254

5.  A seven year survey of antibiotic susceptibility and its relationship with usage.

Authors:  R J Courcol; M Pinkas; G R Martin
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

6.  Preserving the miracle of antibiotics.

Authors:  D Greenwood
Journal:  Lancet       Date:  1995-05-27       Impact factor: 79.321

7.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

Authors:  V A Arason; K G Kristinsson; J A Sigurdsson; G Stefánsdóttir; S Mölstad; S Gudmundsson
Journal:  BMJ       Date:  1996-08-17

8.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

Review 9.  Changing patterns of infectious disease.

Authors:  M L Cohen
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group.

Authors:  C H Ballow; J J Schentag
Journal:  Diagn Microbiol Infect Dis       Date:  1992-02       Impact factor: 2.803

View more
  5 in total

1.  Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.

Authors:  Sitara Swarna Rao Ajjampur; Rajiv Sarkar; Geneve Allison; Kalyan Banda; Anne Kane; Jayaprakash Muliyil; Elena Naumova; Honorine Ward; Gagandeep Kang
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

2.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

3.  Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.

Authors:  Alison Freifeld; Jayashri Sankaranarayanan; Fred Ullrich; Junfeng Sun
Journal:  Support Care Cancer       Date:  2007-10-18       Impact factor: 3.603

4.  A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

Authors:  José-María López-Lozano; Timothy Lawes; César Nebot; Arielle Beyaert; Xavier Bertrand; Didier Hocquet; Mamoon Aldeyab; Michael Scott; Geraldine Conlon-Bingham; David Farren; Gábor Kardos; Adina Fésűs; Jesús Rodríguez-Baño; Pilar Retamar; Nieves Gonzalo-Jiménez; Ian M Gould
Journal:  Nat Microbiol       Date:  2019-04-08       Impact factor: 17.745

Review 5.  What should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature.

Authors:  Maria Arepeva; Alexey Kolbin; Alexey Kurylev; Julia Balykina; Sergey Sidorenko
Journal:  Front Microbiol       Date:  2015-04-29       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.